HistoSonics, the developer of the Edison® Histotripsy System, has announced the enrollment of the first patients in its novel BOOMBOX study, a prospective master protocol designed to assess the real-world…
BrightHeart, an innovator in AI technology for obstetrics and pediatric cardiology, has received FDA 510(k) clearance for its first AI-driven software, which aims to revolutionize prenatal ultrasound evaluations of the…
Cardinal Health (NYSE: CAH) announced the signing of definitive agreements to acquire two key companies that align with its growth strategy and will enhance patient care. The acquisitions include a…
HCA Healthcare, one of the nation’s leading healthcare providers, has been named a Best for Vets Employer by Military Times for the fifth consecutive year, in recognition of its ongoing…
Synthekine Inc., a company specializing in engineered cytokine therapeutics, today announced that promising preclinical results from its murine STK-009 + SYNCAR-001 program will be presented at the American College of…
Hero Digital, a leading digital customer experience agency, has won several prestigious eHealthcare Leadership Awards for its outstanding work with UNC Health and Atlantic Health System. These awards recognize the…
Almirall, S.A. (ALM), a global biopharmaceutical company based in Barcelona, today reported its financial results for the first nine months of 2024. The company posted strong sales growth, primarily driven…
Baxter International Inc. (NYSE: BAX), a global leader in medical technology, announced today its financial results for the third quarter of 2024, highlighting strong performance despite ongoing challenges. “Despite facing…
Sunshine Health, Florida’s largest managed care organization and a subsidiary of Centene Corporation (NYSE: CNC), has announced the appointment of Charlene Zein as Plan President and Chief Executive Officer, effective…
Tempus AI, Inc. (NASDAQ: TEM), a leader in AI-driven precision medicine, has announced the clinical launch of its Immune Profile Score (IPS) algorithmic test. Now available for clinicians to order,…
Endologix LLC, a global leader in medical devices for vascular disease, today revealed the final 36-month results of its DETOUR2 Study. The DETOUR System provides an innovative solution for treating…
LumiThera Inc., a medical device company specializing in photobiomodulation (PBM) therapy for ocular conditions, today announced that the U.S. Food and Drug Administration (FDA) has granted marketing authorization for its…